LONDON (dpa-AFX) - Dental products maker Dentsply International Inc. (XRAY) announced that it has received regulatory approval from the relevant national competition authorities to proceed with the acquisition of the shares of Astra Tech AB, a provider of dental implant and urology products, based in Mölndal, Sweden, from AstraZeneca Plc (AZN, AZN.L).
The previously announced transaction is now expected to close on August 31, 2011.
In June 2011, Dentsply had said that it agreed to buy the Swedish healthcare and dental business, Astra Tech AB, of pharmaceutical firm AstraZeneca for about $1.8 billion in cash.
Copyright RTT News/dpa-AFX
© 2011 AFX News
